Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Healthcare providers should counsel patients about the distinction between compounded and FDA-approved products
An analysis of six clinical trials found that AOD 9604 had a safety profile comparable to placebo and did not act through the IGF-1 pathway
For current self-pay rates, the best step is to call our front desk at 863-282-2082
It acts as a potent agonist of the ghrelin receptor (GHS-R1a), promoting robust stimulation of endogenous growth hormone (GH) release
However, it lacks the clinical trial data and regulatory approval of GLP-1 agonists, and its effects may be more modest
If using a vial : Wipe the rubber stopper with an alcohol swab
US$ 26.79
US$ 28.73
US$ 29.64
US$ 23.91
US$ 29.17
US$ 20.52
US$ 27.69
